Hyponatraemia is a condition where the level of sodium in the blood drops below normal, creating an imbalance that can affect how the body functions. Treatment approaches vary depending on the cause and severity of the condition, aiming to restore sodium levels safely while addressing the underlying health issue. From adjusting fluid intake to using intravenous solutions and medications, managing this common electrolyte disorder requires careful medical guidance to avoid complications.

Understanding Treatment Goals in Hyponatraemia

When doctors approach the treatment of hyponatraemia, their main goal is to restore the balance between sodium and water in your body safely and effectively. The treatment plan depends heavily on how quickly the sodium levels dropped, how severe the imbalance is, and what underlying condition caused it in the first place. This means that each person’s treatment journey may look quite different from another’s, even if they have the same sodium numbers on their lab reports.^[1]

The approach to treating hyponatraemia is not one-size-fits-all. Medical professionals must consider whether your symptoms appeared suddenly or developed gradually over time. Rapid drops in sodium can cause severe brain swelling and require urgent intervention, while gradual decreases often allow the body to adapt, making symptoms less severe. The speed at which treatment proceeds matters enormously because correcting sodium levels too quickly can cause serious complications, while correcting them too slowly may leave you suffering from troubling symptoms longer than necessary.^[2]

Standard treatments approved by medical societies exist for hyponatraemia, but researchers continue to explore new therapies through clinical trials. These investigations look at innovative ways to manage fluid balance, block certain hormones that contribute to the problem, and help the kidneys regulate sodium more effectively. The goal is always to improve quality of life by reducing symptoms like nausea, confusion, weakness, and headaches while preventing dangerous complications such as seizures or loss of consciousness.^[4]

Standard Treatment Approaches

The foundation of treating hyponatraemia lies in identifying what caused the sodium imbalance and tailoring the treatment to that specific cause. Doctors classify hyponatraemia based on your body’s fluid status, which means they assess whether you have too much fluid, too little fluid, or normal fluid levels with diluted sodium. This classification guides the entire treatment strategy.^[2]

For people who have developed hyponatraemia because they retain too much water in their body, the primary treatment often involves fluid restriction. This means limiting how much water and other liquids you drink each day. While it may sound simple, fluid restriction can be challenging to maintain, especially for people who feel thirsty or are used to drinking large amounts of beverages throughout the day. Doctors typically recommend limiting fluid intake to somewhere between 800 and 1,000 millilitres per day, though the exact amount varies based on individual circumstances. This approach works by allowing your kidneys to gradually eliminate excess water while keeping sodium at more stable levels.^[7]

When hyponatraemia occurs alongside dehydration or significant fluid loss from vomiting, diarrhoea, or excessive sweating, the treatment shifts to replacing both sodium and fluids. In these cases, doctors may use isotonic saline, which is a salt solution given through an intravenous line. This solution contains sodium and water in proportions that match the body’s normal concentration, helping to restore balance without causing rapid swings in sodium levels. The fluid is delivered slowly and carefully, with frequent blood tests to monitor progress and adjust the treatment as needed.^[9]

For severe, symptomatic hyponatraemia where someone is experiencing confusion, seizures, or altered consciousness, doctors turn to hypertonic saline, which is a more concentrated salt solution typically containing three percent sodium chloride. This treatment requires hospitalization because it must be monitored very closely. The solution is usually given as small boluses of 100 to 150 millilitres at a time, with sodium levels checked after each dose. The goal is to raise sodium levels by about 4 to 6 milliequivalents per litre in the first few hours to relieve dangerous symptoms while avoiding overcorrection, which can damage the brain’s protective covering in a condition called osmotic demyelination syndrome.^[9][7]

In situations where hyponatraemia develops because of excess fluid retention related to heart failure, liver disease, or kidney problems, doctors may prescribe diuretics, commonly known as water pills. However, this requires careful consideration because some diuretics, particularly thiazides, can actually worsen hyponatraemia by causing the body to lose more sodium than water. Instead, doctors often use loop diuretics such as furosemide, which help the kidneys eliminate excess water while retaining relatively more sodium. These medications need to be dosed carefully and combined with dietary sodium adjustments to achieve the right balance.^[9]

Many cases of hyponatraemia are caused by medications, making it crucial to review all drugs a person is taking. Thiazide diuretics, certain antidepressants, pain medications, and several other commonly prescribed drugs can interfere with the body’s ability to regulate water and sodium. When medications are identified as the culprit, doctors may reduce the dose, switch to an alternative medication, or discontinue the drug altogether if it is safe to do so. This adjustment alone can resolve hyponatraemia in many cases, particularly in older adults who are more susceptible to medication-induced sodium imbalances.^[6]

Treatment duration varies considerably. Some people recover within days once the underlying cause is addressed, while others with chronic conditions require ongoing management over months or even years. During treatment, frequent blood tests monitor sodium levels, kidney function, and other electrolytes like potassium. These tests help doctors adjust treatment plans in real time and catch any problems early. The frequency of monitoring depends on severity, with severe cases requiring blood draws every few hours initially, while stable chronic hyponatraemia might only need weekly or monthly checks.^[11]

Side effects of treatment can occur, particularly if sodium levels rise too quickly. As mentioned, osmotic demyelination syndrome is a serious complication where brain cells are damaged by rapid changes in fluid balance. Symptoms of this condition include difficulty speaking, swallowing problems, confusion, and weakness. To prevent this, doctors carefully calculate correction rates and often use the guideline of raising sodium by no more than 6 to 8 milliequivalents per litre in a 24-hour period for chronic hyponatraemia. For acute hyponatraemia that developed within 48 hours, slightly faster correction may be safer because the brain has not had time to adapt to low sodium levels.^[9][13]

Treatment Options in Clinical Trials

Beyond standard treatments, researchers are actively investigating new approaches to managing hyponatraemia through clinical trials. One of the most promising areas of research involves a class of medications called vaptans, also known as vasopressin receptor antagonists. These drugs work by blocking the action of a hormone called vasopressin, also known as antidiuretic hormone, which normally signals the kidneys to hold onto water. When this hormone is blocked, the kidneys release more water while retaining sodium, helping to correct the imbalance that causes hyponatraemia.^[7][14]

The most studied vaptan is tolvaptan, which specifically targets the V2 receptors in the kidneys where vasopressin normally acts. Clinical trials have tested tolvaptan in people with hyponatraemia caused by heart failure, liver cirrhosis, and the syndrome of inappropriate antidiuretic hormone secretion. These studies, which include Phase II and Phase III trials comparing tolvaptan to placebo or standard treatment, have shown that the medication can effectively raise sodium levels in many patients. Trial participants often experienced improvements in sodium concentration within days of starting treatment, with some studies showing increases of 5 to 10 milliequivalents per litre over the course of treatment.^[11]

The mechanism of action for vaptans is quite specific. By blocking vasopressin receptors, these medications allow the kidneys to produce more dilute urine, which means more water leaves the body relative to sodium. This creates what doctors call aquaresis, or water excretion, as opposed to diuresis, which involves losing both water and electrolytes. This selective action makes vaptans particularly useful for treating certain types of hyponatraemia where the problem is too much water retention rather than sodium loss.^[11]

Clinical trials have revealed both benefits and limitations of vaptan therapy. On the positive side, studies have shown that these medications work relatively quickly and can be effective when fluid restriction alone is not sufficient or practical. Patients in trials have reported improvements in symptoms like fatigue, confusion, and general well-being as their sodium levels normalized. However, the trials have also identified concerns. Some participants developed liver function abnormalities, particularly with longer-term use, leading to requirements for regular liver monitoring. Additionally, vaptans can cause excessive thirst and increased urination, which can be bothersome for some people.^[11]

Safety data from clinical trials suggest that vaptans should not be used in certain situations. They are not recommended for people with severe liver disease, those who cannot sense or respond to thirst, or in cases requiring rapid correction of sodium levels. The trials also showed that these medications should not be used as a first-line treatment for all hyponatraemia, but rather reserved for specific situations where euvolemic or hypervolemic hyponatraemia persists despite other interventions. Current consensus guidelines suggest that vaptans may be appropriate for carefully selected patients but should not be used routinely.^[7][14]

Another substance being investigated in clinical trials is urea, a naturally occurring compound that the body produces as a waste product from protein metabolism. When given as a treatment supplement, urea can help correct hyponatraemia by creating an osmotic effect that promotes water excretion by the kidneys. Some studies have explored using urea as an alternative to fluid restriction or in combination with it, particularly for people with the syndrome of inappropriate antidiuretic hormone secretion. The trials have shown mixed results, with some demonstrating effectiveness in raising sodium levels, while others found the treatment difficult for patients to tolerate due to taste and gastrointestinal side effects.^[9]

Clinical research is also examining different formulations and delivery methods for hypertonic saline. Some trials are testing continuous infusion versus intermittent boluses, trying to determine which approach achieves the best balance between effectiveness and safety. These studies involve detailed monitoring of sodium levels, brain function, and symptoms to establish optimal protocols for emergency treatment of severe hyponatraemia. Early results suggest that intermittent boluses may be easier to control and adjust based on individual patient response.^[11]

Researchers are exploring the use of demeclocycline, an antibiotic that has the unusual side effect of reducing the kidneys’ response to vasopressin. While not a new discovery, this medication is being studied more systematically in trials to better understand its role in treating chronic hyponatraemia, particularly in cases where other treatments have failed. The trials are assessing dosing strategies, duration of treatment, and which patient populations benefit most from this approach. However, demeclocycline can cause side effects including sensitivity to sunlight and kidney problems, which limits its widespread use.^[8]

Trial phases matter when evaluating these treatments. Phase I trials focus on safety and determining the right dose in small groups of healthy volunteers or patients. Phase II trials expand testing to larger groups to evaluate both effectiveness and safety in people with the condition. Phase III trials compare the new treatment directly against standard care in large, diverse patient populations to confirm benefits and monitor for uncommon side effects. Many of these hyponatraemia studies have progressed through multiple phases, with some leading to regulatory approval in certain countries or for specific indications.^[11]

Patient eligibility for clinical trials varies depending on the specific study. Generally, trials enroll adults with confirmed hyponatraemia of a certain severity, often requiring sodium levels below 130 or 125 milliequivalents per litre. Many trials exclude people with very severe symptoms requiring emergency treatment, those with certain other medical conditions, and pregnant or breastfeeding women. Some trials focus specifically on particular causes of hyponatraemia, such as heart failure or cancer-related conditions. Trials are conducted at major medical centres in various countries including the United States, across Europe, and in other regions. Interested patients should discuss trial participation with their doctors, who can help determine if any available studies might be appropriate for their situation.^[11]

Most Common Treatment Methods

• Fluid Restriction
  • Limiting daily water and beverage intake to allow gradual correction of excess water relative to sodium
  • Typically involves restricting fluids to 800-1,000 millilitres per day depending on individual needs
  • Main approach for euvolemic hyponatraemia where the body has normal sodium but excess water
  • Can be challenging to maintain but effective when followed consistently^[7]
• Intravenous Saline Solutions
  • Isotonic saline (0.9% sodium chloride) used for hyponatraemia with fluid depletion or dehydration
  • Hypertonic saline (3% sodium chloride) given in small boluses of 100-150 millilitres for severe symptomatic cases
  • Requires hospitalization with frequent sodium monitoring to prevent overcorrection
  • Goal is to raise sodium by 4-6 milliequivalents per litre in first few hours for symptomatic relief^[9][7]
• Diuretic Medications
  • Loop diuretics like furosemide help remove excess water while retaining relatively more sodium
  • Used in hypervolemic hyponatraemia associated with heart failure, liver disease, or kidney problems
  • Must be dosed carefully as some diuretics can worsen hyponatraemia
  • Often combined with dietary sodium adjustments and fluid management^[9]
• Medication Adjustment
  • Reviewing and modifying drugs that can cause hyponatraemia, particularly thiazide diuretics and certain antidepressants
  • May involve reducing doses, switching to alternative medications, or discontinuing problematic drugs
  • Can resolve hyponatraemia in many cases, especially in older adults
  • Common causes include diuretics, SSRIs, pain medications, and various other prescription drugs^[6]
• Vasopressin Receptor Antagonists (Vaptans)
  • Medications like tolvaptan that block vasopressin hormone action in kidneys
  • Promote selective water excretion while retaining sodium through aquaresis
  • Used for euvolemic and hypervolemic hyponatraemia when other treatments are insufficient
  • Require liver function monitoring and are not suitable for all patients
  • Reserved for specific situations rather than routine first-line treatment^[11][14]
• Urea Supplementation
  • Naturally occurring compound given as treatment supplement to promote water excretion
  • Alternative or addition to fluid restriction for syndrome of inappropriate antidiuretic hormone secretion
  • Can be difficult to tolerate due to taste and gastrointestinal effects
  • Studied in clinical trials with mixed results^[9]
• Treatment of Underlying Conditions
  • Addressing root causes such as heart failure, liver cirrhosis, kidney disease, or hormonal disorders
  • Managing conditions like hypothyroidism or adrenal insufficiency that affect sodium regulation
  • Treating syndrome of inappropriate antidiuretic hormone secretion and identifying its cause
  • Essential component alongside direct sodium correction measures^[2][4]